Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens

Cancer Cytopathology

Volumn 118, Issue 1, 2010, Pages 47-55

  Yu, Li ^a,b   Wang, Liantang ^a   Zhong, Juemin ^a   Chen, Shangwu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Orthopedic Trauma Hospital   (China)

Author keywords

Cell block preparations; Cervical intraepithelial neoplasia; Human papillomavirus L1 capsid protein; Immunocytochemistry; Ki 67; Liquid based cytology; P16INK4A

Indexed keywords

CAPSID PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; KI 67 ANTIGEN; ONCOPROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CYTODIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; PRECANCER; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTODIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77950507520     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20061     Document Type: Article

References (35)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999; 80:827-841.
2. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989;261:737-743.
3. DeMay R. The Pap smear. In: DeMay R, ed. The Art and Science of Cytopathology. Chicago, Ill: American Society of Clinical Pathologists Press;1996:61-205.
4. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.
5. Klinkhamer PJ, Meerding WJ, Rosier PF, Hanselaar AG. Liquid-based cervical cytology. Cancer. 2003;99:263-271.
6. Richard K, Dziura B, Hornish A. Cell block preparation as a diagnostic technique complementary to fluid-based monolayer cervicovaginal specimens. Acta Cytol. 1999;43:69-73.
7. Yeoh GP, Chan KW. Cell block preparation on residual ThinPrep sample. Diagn Cytopathol. 1999;21:427-431.
8. Keyhani-Rofagha S, Vesey-Shecket M. Diagnostic value, feasibility, and validity of preparing cell blocks from fluid-based gynecologic cytology specimens. Cancer. 2002;96: 204-209.
9. Ozbun MA, Meyers C. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J Virol. 1998;72:2715-2722.
10. Doorbar J. The papillomavirus life cycle. J Clin Virol. 2005;32(suppl 1):S7-S15.
11. Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study. Cancer. 2008;114:474-480.
12. Kalof AN, Cooper K. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 2006;13:190-194.
13. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK. Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol. 2003;200:610-619.
14. Makitie AA, MacMillan C, Ho J, et al. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res. 2003;9:2177-2184.
15. Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 1999;59:6132-6136.
16. Klaes R, Benner A, Friedrich T, et al. p16INK4a immuno-histochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399.
17. Kruse AJ, Baak JP, de Bruin PC, et al. Ki-67 immuno-quantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol. 2001;193:48-54.
18. Nam EJ, Kim JW, Hong JW, et al. Expression of p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol. 2008;19:162-168.
19. Aoyama C, Liu P, Ostrzega N, Holschneider CH. Histologic and immunohistochemical characteristics of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix. Am J Clin Pathol. 2005;123: 699-706.
20. Griesser H, Sander H, Hilfrich R, Moser B, Schenck U. Correlation of immunochemical detection of HPV L1 capsid protein in Pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Anal Quant Cytol Histol. 2004;26:241-245.
21. Rauber D, Mehlhorn G, Fasching PA, Beckmann MW, Ackermann S. Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. Eur J Obstet Gynecol Reprod Biol. 2008;140:258-262.
22. Saqi A, Pasha TL, McGrath CM, Yu GH, Zhang P, Gupta P. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol. 2002;27:365-370.
23. Liu H, Shi J, Wilkerson M, et al. Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections. Cancer. 2007;111:74-82.
24. Duncan L, Jacob S, Hubbard E. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. Cancer. 2008;114:34-48.
25. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-891.
26. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol. 2003;56:56-63.
27. Akpolat I, Smith DA, Ramzy I, Chirala M, Mody DR. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material. Cancer. 2004;102:142-149.
28. Yu L, Peng J, Chen S. Expression of p16INK4A and Ki-67 in cervical intraepithelial neoplasia. J Clin Exp Pathol. 2007; 23:665-668.
29. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
30. Branca M, Ciotti M, Santini D, et al. p16(INK4A) expression is related to grade of cin and high-risk human papillo-mavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol. 2004;23:354-365.
31. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186-192.
32. Melsheimer P, Kaul S, Dobeck S, Bastert G. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta Cytol. 2003;47:124-128.
33. Birner P, Bachtiary B, Dreier B, et al. Signal-amplified colorimetric in situ hybridization for assessment of human papillo-mavirus infection in cervical lesions. Mod Pathol. 2001;14:702-709.
34. Negri G, Bellisano G, Zannoni GF, et al. p16INK4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol. 2008;32:1715-1720.
35. Yoshida T, Sano T, Kanuma T, et al. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer. 2008;114:83-88